For two decades, leukaemia stem cells (LSCs) in chronic myeloid leukaemia (CML) and
acute myeloid leukaemia (AML) have been advanced paradigms for the cancer stem cell …

Chronic myeloid leukemia (CML) is caused by the acquisition of the tyrosine kinase BCR-
ABL1 in a hemopoietic stem cell, transforming it into a leukemic stem cell (LSC) that self …

Diverse subsets of endothelial progenitor cells (EPCs) are used for the treatment of ischemic
diseases in clinical trials, and circulating EPCs levels are considered as biomarkers for …

Glioblastoma (GBM) is the most malignant brain tumor and is highly resistant to intensive
combination therapies and anti-VEGF therapies. To assess the resistance mechanism to anti …

The limited vessel-forming capacity of infused endothelial progenitor cells (EPCs) into
patients with cardiovascular dysfunction may be related to a misunderstanding of the …

Background—Endothelial progenitor cells (EPCs) circulate in adult peripheral blood (PB)
and contribute to neovascularization. However, little is known regarding whether EPCs and …

Leukemia can be viewed as a newly formed, abnormal hematopoietic tissue initiated by a
few leukemic stem cells (LSCs) that undergo an aberrant and poorly regulated process of …

Acute myelogenous leukemia is propagated by a subpopulation of leukemia stem cells
(LSCs). In this article, we review both the intrinsic and extrinsic components that are known …

Recent evidence indicates that vascular progenitor cells may be the source of smooth
muscle cells (SMCs) that accumulate in atherosclerotic lesions, but the origin of these …

In the past decade, researchers have defined committed stem or progenitor cells from
various tissues, including bone marrow, peripheral blood, brain, liver, and reproductive …